The influenza virus NS1 protein acts as a novel inhibitor of host pre-mRNA splicing by binding to spliceosomes, though its own mRNA is resistant.
Answers are grounded in this paper and cite their sources.
May inform antiviral strategies targeting viral host shutoff; leaves open relevance to human influenza pathogenesis.
We have shown previously that the influenza virus NS1 protein inhibits the nuclear export of mRNAs. Here we demonstrate that the NS1 protein also regulates another post-transcriptional step: It inhibits pre-mRNA splicing both in vivo and in vitro. The mode by which the NS1 protein inhibits pre-mRNA splicing is novel. The pre-mRNA forms spliceosomes, but subsequent catalytic steps in splicing are inhibited. Affinity selection experiments establish that the NS1 protein is associated with the spliceosomes that are formed. The RNA-binding domain of the NS1 protein is required for the inhibition of splicing and for the interaction of the protein with spliceosomes. Because the NS1 protein is associated with U6 snRNA in influenza virus-infected cells as well as in splicing extracts from uninfected cells, it is likely that the NS1 protein also inhibits pre-mRNA splicing in infected cells. Surprisingly, the splicing of the viral ns1 mRNA, the very mRNA that encodes the NS1 protein, was resistant to inhibition by the NS1 protein. This resistance is conferred by sequences in ns1 mRNA.
No takes yet. Share an insight, caveat, or question.
Lu et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: